National Healthcare Properties, Inc.
NHPReal Estate Reit Healthcare Facilities
National Healthcare Properties, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $342.3 million, down 3.25% from fiscal 2024.
- Revenue
- +19.8%
- EPS
- n/m
- Free cash flow
- n/m
- Total debt
- +79.0%
Quarter to September 2026, against a year earlier
After hours trading: 14.82, unchanged, last trade Fri 4:01pm Eastern.
Follow NHP
Alert me
Ratios over time Q4 FY25 to Q3 FY26
Returns on capital
ROIC was 1.83% in Q3 FY26, the highest of these four quarters.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| ROE | −11.0% | −11.5% | −6.7% | −3.1% |
| ROIC | 0.2% | 0.0% | 0.6% | 1.8% |
Debt
Net debt is 8.25× a year’s EBITDA. Debt is 0.65× equity, against 1.12× in Q1 FY26.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Debt / equity | 1.1× | 1.1× | 0.5× | 0.7× |
| Net debt / EBITDA | 44.6× | 20.6× | 8.0× | 8.2× |
Cash cycle, in days
Customers pay in 28 days and suppliers are paid in 192. Suppliers fund 164 days of working capital.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Cash cycle | −41 | −40 | −52 | −164 |
| Days to pay suppliers | 74 | 73 | 82 | 192 |
| Days to be paid | 33 | 33 | 31 | 28 |
Per share, from Q4 FY25
Since Q4 FY25, per share: revenue has fallen 58.9%; book value has fallen 40.6%.
| Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | |
|---|---|---|---|---|
| Free cash flow | 1.0× | 0.3× | −0.4× | −0.7× |
| Revenue | 1.0× | 1.0× | 0.5× | 0.4× |
| Book value | 1.0× | 1.0× | 0.8× | 0.6× |
| Older periods | Dec '25 | Mar '26 | Jun '26 | Sep '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
5 | 6 | 6 | 7 |
| (10.98%) | (11.54%) | (6.74%) | (3.08%) | ||
| (3.89%) | (4.17%) | (3.08%) | (1.31%) | ||
ROIC |
0.18% | 0.02% | 0.56% | 1.83% | |
Return on Tangible Assets |
(6.73%) | (7.05%) | (3.83%) | (2.05%) | |
Average Days of Receivables |
32.78 | 33.02 | 30.83 | 28.03 | |
Free Cash Flow per Share |
2.76 | 0.88 | (1.02) | (1.82) | |
Free Cash Flow |
78.14 | 25.07 | (62.85) | (132.07) | |
Capital Expenditures |
71.19 | (12.12) | (113.60) | (188.39) | |
| Other line items | |||||
Cash ROIC |
5.65% | 1.83% | (3.42%) | (7.92%) | |
Accounts Receivable Turnover |
11.52 | 11.60 | 11.73 | 12.24 | |
Accounts Payable Turnover |
3.27 | 4.40 | 4.52 | 2.74 | |
Average Days of Payables |
74.00 | 72.85 | 82.33 | 192.41 | |
Tax Rate |
0.00 | 0.00 | 0.01 | 0.01 | |
Selling, General and Administrative Expense of Revenue |
7.07% | 7.24% | 7.64% | 7.87% | |
Share Based Compensation of Revenue |
1.10% | 1.28% | 1.57% | 1.72% | |
Interest Coverage |
0.05 | 0.01 | 0.19 | 0.73 | |
Operating CF/Net income |
(0.10) | (0.50) | (0.88) | (2.35) | |
Depreciation/Fixed assets |
0.06 | 0.05 | 0.05 | 0.05 | |
Capex/Depreciation |
0.84 | (0.16) | (1.57) | (2.44) | |
Revenue per Share |
12.09 | 12.07 | 5.59 | 4.97 | |
Operating CF per Share |
0.25 | 1.31 | 0.82 | 0.78 | |
Capex per Share |
2.52 | (0.43) | (1.84) | (2.59) | |
Capex to Sales |
(0.21) | 0.04 | 0.33 | 0.52 |